Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Introduction to CAA
- Variable presentation and course
- Lobar intracerebral hemorrhage
- Risk factors for CAA-related ICH
- Clinical presentation
- Imaging characteristics
- CAA-related ICH: long-term outcome
- CAA-related ICH: risk of recurrence
- Post-ICH cognitive impairment
- CAA and depression after ICH
- Neuropsychiatric Symptoms (NPs) and CAA
- Cognitive impairment and dementia (1)
- Cognitive impairment and dementia (2)
- CAA pathology and cognitive domains
- Potential mechanisms of cognitive impairment in CAA
- Transient Focal Neurological Episodes (TFNEs)
- Clinical presentation of TFNEs (1)
- Clinical presentation of TFNEs (2)
- Imaging presentation
- Diagnostic characteristics of CAA-related TFNE
- Frequency of CAA-related TFNE
- Pathophysiology
- Clinical management of CAA-related TFNE (1)
- Clinical management of CAA-related TFNE (2)
- Conclusions
- Acknowledgements
Topics Covered
- Presentation of Cerebral Amyloid Angiopathy (CAA)
- Lobar intracerebral hemorrhage (ICH)
- Risk factors for CAA-related ICH
- Imaging characteristics of CAA
- Post-ICH cognitive impairment
- Cognitive impairment and dementia
- Transient Focal Neurological Episodes (TFNEs)
- Clinical presentation of TFNEs
- Diagnostic characteristics of CAA-related TFNE
- Clinical management of CAA-related TFNE
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Pasi, M. (2023, October 31). Common clinical phenotypes in cerebral amyloid angiopathy [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 22, 2024, from https://doi.org/10.69645/CSJC3647.Export Citation (RIS)
Publication History
Financial Disclosures
- There are no commercial/financial matters to disclose.
Other Talks in the Series: Cerebral Amyloid Angiopathy (CAA)
Transcript
Please wait while the transcript is being prepared...
0:00
Hello everyone. My
name is Marco Pasi.
I'm a vascular
neurologist working at
the University
Hospital of Tours,
in the neurology department.
Today, I will speak about
the common clinical
phenotype that we
can encounter in cerebral
amyloid angiopathy (CAA).
0:24
Sporadic CAA can manifest with
a widespread range of
clinical manifestations.
Because CAA has been reported
in individuals without
'clear-cut symptoms', in
up to 24% of the
general population,
we can find moderate to severe
CAA in pathology reports.
Moreover, CAA is consider
part of the process,
also of normal aging,
but in certain cases,
CAA can manifest with
progressive symptoms,
with an insidious
clinical course,
such as mild
cognitive complaints,
but cognitive impairment can
reach stages of severe dementia.
Furthermore, we can also have
patients with mild
depressive symptoms,
but also other neuropsychiatric
manifestations,
but CAA has also been
associated to abrupt and
dramatic clinical presentations.
This is the case of
intracerebral hemorrhage (ICH),
especially in elderly people,
but also transient focal
neurological episodes,
also known as the amyloid spell.
In this presentation, I will
not speak about
inflammatory CAA.